Close Menu

Biotech company Geron, long known for its pioneering research on stem cells, has announced that it will no longer conduct such research, reports New Scientist's Andy Coghlan. Geron's stem cell program was the largest in the world, and currently runs trials to treat various disorders and diseases with stem cell therapies, including one to treat people with spinal injuries, Coghlan says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.